ChiCTR1800014741
正在进行
/
/
/
2018-01-31
/
/
注意缺陷多動障礙症
The effects of a mindfulness based intervention - MYmind - for children with ADHD and their parents: a randomised controlled trial
The effects of a mindfulness based intervention - MYmind - for children with ADHD and their parents: a randomised controlled trial
1. To evaluate the effectiveness of a mindfulness based intervention - MYmind - in improving childrens attention, behaviour and executive function as well as reducing impulsivity associated with ADHD in children diagnosed with ADHD aged 8 to 12 years in Hong Kong; 2. To evaluate the effectiveness of MYmind in reducing parental stress and ADHD symptoms and improving well-being and parenting style among parents of children diagnosed with ADHD; 3. To further evaluate the acceptability of MYmind for children diagnosed with ADHD and their parents in Hong Kong Chinese.
随机平行对照
治疗新技术
The randomisation will be conducted by an experienced independent statistician in an 1:1 ratio with computer-generated random numbers.
The research staff member who conducts the assessments or statistical analysis will be kept blinded of the group assignment.
General Research Fund, University Grants Committee, Hong Kong SAR
/
140
/
2018-01-01
2020-12-31
/
1) children aged 8 to 12 years with psychiatrist or psychologist diagnosed ADHD according to the Diagnostic and Statistical Manual of Mental Disorders - 5 (DSM-5) diagnostic criteria and ADHD status being re-confirmed by clinically elevated inattentive and/or hyperactive-impulsive symptoms as indicated by T-scores of either parent and teacher versions of Strengths and Weaknesses of ADHD-symptoms and Normal-behaviour (SWAN, Chinese version) at or above 95th percentile, or both parent and teacher versions of the SWAN (Chinese version) at or above 85th percentile; 2) with normal intellectual ability such that they can understand the materials delivered in MYmind and that they can complete home practice each week; 3) children either not taking any medication or taking a stable dosage of the same medication for ADHD for at least 3 months prior to study enrolment and having no plan for changing medication during the study period.；
登录查看The exclusion criteria of children and parents are: 1) being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese; 2) the child having comorbid conduct/behavior problems which are so severe that, during intake, the interaction between parent and clinician is interrupted by the child within 2 minutes, which makes it impossible for the child to participate in a group training. Instructions of this criterion are adapted from the Autism Diagnostic Observation Schedule (ADOS) and will be provided to the clinician to facilitate to examine whether the child may be or may not be able to participate in a group training in addition to the clinicians expertise; 3) having a medical or mental health condition rendering him/her to be incapable of participating in the study; 4) previous participation in mindfulness-based training.；
登录查看General Research Fund, University Grants Committee, Hong Kong SAR
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
